JSPR: Jasper Therapeutics, Inc. Stock

by  •  • Comments Off on JSPR: Jasper Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 361.75
Enterprise Value ($M) 274.86
Book Value ($M) 78.44
Book Value / Share 5.20
Price / Book 4.61
NCAV ($M) 72.49
NCAV / Share 4.80
Price / NCAV 4.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 7.19
Current Ratio 7.19

Balance Sheet (mrq) ($M)
Current Assets 88.94
Assets 94.89
Liabilities 16.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -68.86
Net Income -64.47

Cash Flow Statement (mra) ($M)
Cash From Operations -52.07
Cash from Investing -0.27
Cash from Financing 100.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-27 13G Avidity Partners Management LP 5.10
02-14 13G/A Qiming U.S. Healthcare Fund II, L.P. 6.20
02-09 13D/A Velan Capital Investment Management LP 9.80
02-02 13G/A Soleus Capital Master Fund, L.P. 8.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 9,827 56,463 17.40
2024-05-02 14,681 19,321 75.98
2024-05-01 10,783 38,315 28.14
2024-04-30 16,536 35,836 46.14
2024-04-29 8,482 11,756 72.15

(click for more detail)

Similar Companies
ITRM – Iterum Therapeutics plc JAGX – Jaguar Health, Inc.
JAN – JanOne Inc. KA – Kineta, Inc.
KALA – KALA BIO, Inc.


Financial data and stock pages provided by
Fintel.io